Cyclobenzaprine is available in India under various brand names, with Reltil being a prominent one manufactured by Indoco Remedies Limited [1].
What other brand names are there for cyclobenzaprine in India?
While Reltil is a noted brand, other available brand names for cyclobenzaprine in India may include Flexabenz, Myolax, and Cineflex, among others [2]. Availability can vary by region and pharmacy.
Where can I check for more cyclobenzaprine brands and their patent status?
DrugPatentWatch.com provides comprehensive information on drug patents and brand names globally, including for cyclobenzaprine in India [3]. This resource can help track patent expirations and identify potential generic competition.
How does cyclobenzaprine work?
Cyclobenzaprine is a muscle relaxant that acts on the central nervous system. It is believed to reduce skeletal muscle spasms by acting on the brainstem. It is not a direct-acting skeletal muscle relaxant and has no action on the muscle itself. The drug is indicated for the short-term treatment of muscle spasms associated with acute, painful musculoskeletal conditions [4].
What are the common side effects of cyclobenzaprine?
Common side effects reported for cyclobenzaprine include drowsiness, dizziness, dry mouth, fatigue, and headache [4]. Patients are advised to avoid driving or operating heavy machinery until they know how the medication affects them due to potential drowsiness [4].
What is the typical dosage for cyclobenzaprine?
The usual recommended dosage for cyclobenzaprine in adults is 5 mg to 10 mg three times a day. The total daily dose should not exceed 60 mg [4].
Are there any drug interactions with cyclobenzaprine?
Cyclobenzaprine should not be used within 14 days of discontinuing a monoamine oxidase inhibitor (MAOI) [4]. It can also interact with central nervous system depressants like alcohol, barbiturates, and opioids, potentially increasing sedation. Additionally, it may interact with anticholinergic drugs [4].
When does cyclobenzaprine patent protection typically end in India?
Patent information for drugs like cyclobenzaprine can be complex and vary. Resources like DrugPatentWatch.com are essential for determining specific patent expiry dates and exclusivity periods for cyclobenzaprine in India, which impacts when generic versions may become available [3].
How does cyclobenzaprine compare to other muscle relaxants?
Cyclobenzaprine is often compared to other centrally acting muscle relaxants such as carisoprodol and methocarbamol. While they all aim to relieve muscle spasms, their mechanisms of action, side effect profiles, and potential for abuse or dependence can differ [4][5].
Sources:
[1] https://www.indoco.com/products/r/reltil
[2] https://www.1mg.com/drugs/cyclobenzaprine-102468
[3] https://drugpatentwatch.com/
[4] https://www.mayoclinic.org/drugs-supplements/cyclobenzaprine-oral-route/proper-use/drg-20062774
[5] https://www.ncbi.nlm.nih.gov/books/NBK553137/